Supply of medicinal plants in the form of antidiabetic pills and antidiabetic snacks

En supply of medicinal plants in the form of antidiabetic pills and antidiabetic snacks

A clinical trial with a control group, with parallel groups, double-blind, randomized

This study is conducted in Razi University. At the beginning of the study, 1 and 2 months after the study, fasting glucose serum level, glycosylated hemoglobin blood level, 2 hours postprandial glucose serum level are measured.

Based on the calculated sample size, a number of women and men between the ages of 18-65 years old, people prone to type 2 diabetes due to being overweight or suffering from type 2 diabetes with fasting blood sugar more than 125 or sugar after breakfast more than 200 or level Glycosylated hemoglobin more than 6 are included in the study. Pregnant and lactating patients, with glycosylated hemoglobin more than 10, requiring insulin injections, suffering from type chronic and acute kidney, liver, heart, vascular diseases are excluded from the study.

Patients are classified into 5 categories: capsule, cocoa milk, herbal extract, pastille and weight loss. Herbal capsule category into two groups: synthetic drugs plus herbal capsule and synthetic drugs plus placebo, cocoa milk category into two groups: synthetic drugs plus enriched cocoa milk and synthetic drugs plus placebo, herbal extract category into three Group: synthetic drugs plus extract extracted using a new method and synthetic drugs plus extract extracted using a conventional method and synthetic drugs plus placebo, pastille category into two groups: synthetic drugs plus enriched pastille and drugs Artificial in addition to placebo, the weight loss category is divided into two groups: weight loss capsules and placebo.

Fasting glucose serum level; Glycosylated hemoglobin blood level; 2 hours postprandial glucose serum level

Simple randomization is done using a table of random numbers.

In this study, the patients, the prescribing physician, the person in charge of data collection, the researcher who comments on the effectiveness of the product, the person who evaluates the outcomes, and the person who analyzes the data are not aware of the type of drug.